News bits Lacosamide trial: A recent trial of lacosamide (formerly erlosamide) for migraine failed to show impressive results. Lacosamide, sold as Vimpat, is a new anti-seizure medication. Namenda migraine and chronic tension-type headache treatment: Namenda (memantine) shows some promise for chronic tension-type headache, and especially migraine, in some small studies. But we're still waiting for a larger study to clarify the situation. PFO treatment: Simple surgery to close a common hole in the heart for migraine started out showing great promise, but has failed to live up to expectations. However, a new study suggests that it might be more beneficial to migraineurs who have had stroke or have subclinical brain lesions. The Migraine Brain: Don't miss my review of one of the newest books on migraine, The Migraine Brain. Slimmer waistlines and migraine: Don't get your hopes up that this study will change your life. Trigger Points: Moving on with our study on trigger points and various kinds of headache - Trigger Points: Identification, Myths, and Preparing to Fight them You can subscribe to this monthly newsletter, here is the link: James Cottrill [[email protected]] Sparrow
